Medical Condition News

RSS

The Lancet outlines 10 ambitious recommendations to improve health outcomes for women

The Lancet women and cardiovascular disease Commission outlines 10 ambitious recommendations to improve health outcomes for millions of women around the world and achieve the global targets set.

17 May 2021

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Brief pulses of ultrasound delivered to nerves near the kidney produced a clinically meaningful drop in blood pressure in people whose hypertension did not respond to a triple cocktail of medications, reports a new study led by researchers at Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian.

17 May 2021

Retinal scans may provide an early sign of Alzheimer's disease

While it has been said that the eyes are a window to the soul, a new study shows they could be a means for understanding diseases of the brain.

17 May 2021

Older heart failure patients significantly benefit from tailored cardiac rehab program

Older patients hospitalized with acute heart failure who participated in a novel 12-week physical rehabilitation (rehab) program tailored to address their specific physical impairments had significant gains not only in physical functioning but also quality of life and depression compared with those receiving usual care, regardless of their heart's ejection fraction, according to a new study presented at the American College of Cardiology's 70th Annual Scientific Session.

17 May 2021

$Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak$

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

The COVID-19 pandemic has been shown to have caused a significant strain on the healthcare system and resources in the United States.

17 May 2021

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.

17 May 2021

Groundbreaking study optimizes patient's own immune system to fight tumors

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's own immune system to fight tumors.

14 May 2021

Minorities substantially underrepresented in pancreatic cancer clinical trials

Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week 2021.

14 May 2021

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years. In DAPA-CKD Phase III trial, Farxiga demonstrated unprecedented reduction in the risk of the composite of worsening of renal function, end-stage kidney disease and cardiovascular or renal death.

From AstraZeneca 14 May 2021

A look at how coronavirus disease (COVID-19) affects Parkinson's

Earlier, herpes simplex virus (HSV), influenza virus A, measles virus, cytomegalovirus (CMV), and mumps virus have all been associated with after-effects of the virus that includes Parkinson's disease (PD). This list may now include SARS-CoV-2.

14 May 2021

Novel nanotechnology could change the lives of people living with cystic fibrosis

World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold.

13 May 2021

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.

13 May 2021

Insured cancer patients treated at Kaiser Permanente have better survival rates

Among cancer patients with health coverage in Southern California, those who were diagnosed and treated at Kaiser Permanente, an integrated health care organization, had better survival rates, especially Black and Latino patients, according to Kaiser Permanente research published in The American Journal of Managed Care.

13 May 2021

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

The Ayzot app is a collaboration between Surrey, the University of Strathclyde, Hospice Ethiopia, the Federal Ministry of Health and Hello Doctor Ethiopia, an Ethiopian-based software company run by Dr Yohans Wodaje.

13 May 2021

Obesity-related cancer deaths are declining at a slower pace, shows study

Cancer death rates have fallen dramatically in the United States, but factor in obesity, as researchers did at the University of North Carolina Gillings School of Global Public Health, and the picture changes.

13 May 2021

Black fungus complicates India's COVID pandemic

India faces a global health crisis as the number of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections reaches over 23.7 million. As India's health system buckles with increased admissions and a lack of resources, another health threat has emerged.

13 May 2021

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

Researchers in the UK have presented a multi-omics integrated blood atlas that delineates the host immune response in patients with coronavirus disease 2019 (COVID-19) of varying severity, providing a unique reference resource for the interpretation of datasets generated from interventional trials.

13 May 2021

Medical Condition News

The Lancet outlines 10 ambitious recommendations to improve health outcomes for women

Brief pulses of ultrasound delivered to nerves in renal arteries reduce drug-resistant blood pressure

Retinal scans may provide an early sign of Alzheimer's disease

Older heart failure patients significantly benefit from tailored cardiac rehab program

Researchers compare characteristics and outcomes of hip fracture patients during pre- and post-COVID-19 outbreak

Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack

Groundbreaking study optimizes patient's own immune system to fight tumors

Minorities substantially underrepresented in pancreatic cancer clinical trials

Farxiga approved in the US for the treatment of chronic kidney disease in patients at risk of progression with and without type-2 diabetes

A look at how coronavirus disease (COVID-19) affects Parkinson's

Novel nanotechnology could change the lives of people living with cystic fibrosis

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

Insured cancer patients treated at Kaiser Permanente have better survival rates

New app focuses on supporting patients with life-limiting illnesses in Ethiopia

Obesity-related cancer deaths are declining at a slower pace, shows study

Black fungus complicates India's COVID pandemic

Comprehensive blood atlas of COVID-19 identifies hallmarks of disease severity

New study may help develop senolytic drugs that target senescent immune cells

International experts are working to provide evidence-based guidelines for radiation therapy dosing for children

Study describes differences between mutation profile of acral nevi and acral melanoma

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News